These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30039340)

  • 1. CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Aftab A; Shahzad S; Hussain HMJ; Khan R; Irum S; Tabassum S
    Breast Cancer; 2019 Jan; 26(1):11-28. PubMed ID: 30039340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CDKN2A variants in breast cancer patients in Pakistan.
    Khan R; Aftab A; Tabassum S; Hussain HMJ; Hameed A; Mahmood H; Munir F; Bukhari I
    Genes Genet Syst; 2019 Jul; 94(3):117-122. PubMed ID: 31231091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.
    Scaini MC; Minervini G; Elefanti L; Ghiorzo P; Pastorino L; Tognazzo S; Agata S; Quaggio M; Zullato D; Bianchi-Scarrà G; Montagna M; D'Andrea E; Menin C; Tosatto SC
    Hum Mutat; 2014 Jul; 35(7):828-40. PubMed ID: 24659262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common variant of CDKN2A (p16) predisposes to breast cancer.
    Debniak T; Górski B; Huzarski T; Byrski T; Cybulski C; Mackiewicz A; Gozdecka-Grodecka S; Gronwald J; Kowalska E; Haus O; Grzybowska E; Stawicka M; Swiec M; Urbański K; Niepsuj S; Waśko B; Góźdź S; Wandzel P; Szczylik C; Surdyka D; Rozmiarek A; Zambrano O; Posmyk M; Narod SA; Lubinski J
    J Med Genet; 2005 Oct; 42(10):763-5. PubMed ID: 15879498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
    Orlow I; Begg CB; Cotignola J; Roy P; Hummer AJ; Clas BA; Mujumdar U; Canchola R; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Wilcox H; Busam K; From L; Berwick M;
    J Invest Dermatol; 2007 May; 127(5):1234-43. PubMed ID: 17218939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classifying variants of CDKN2A using computational and laboratory studies.
    Miller PJ; Duraisamy S; Newell JA; Chan PA; Tie MM; Rogers AE; Ankuda CK; von Walstrom GM; Bond JP; Greenblatt MS
    Hum Mutat; 2011 Aug; 32(8):900-11. PubMed ID: 21462282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
    J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
    Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
    Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer.
    Kimura H; Klein AP; Hruban RH; Roberts NJ
    Pancreas; 2021 Sep; 50(8):1123-1130. PubMed ID: 34714275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline splicing mutations of CDKN2A predispose to melanoma.
    Loo JC; Liu L; Hao A; Gao L; Agatep R; Shennan M; Summers A; Goldstein AM; Tucker MA; Deters C; Fusaro R; Blazer K; Weitzel J; Lassam N; Lynch H; Hogg D
    Oncogene; 2003 Sep; 22(41):6387-94. PubMed ID: 14508519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.
    Bisio A; Nasti S; Jordan JJ; Gargiulo S; Pastorino L; Provenzani A; Quattrone A; Queirolo P; Bianchi-Scarrà G; Ghiorzo P; Inga A
    Hum Mol Genet; 2010 Apr; 19(8):1479-91. PubMed ID: 20093296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
    Debniak T; Scott R; Masojc B; Serrano-Fernández P; Huzarski T; Byrski T; Debniak B; Górski B; Cybulski C; Medrek K; Kurzawski G; van de Wetering T; Maleszka R; Kładny J; Lubinski J
    Int J Cancer; 2006 Dec; 119(11):2597-602. PubMed ID: 16988943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
    Pjanova D; Engele L; Randerson-Moor JA; Harland M; Bishop DT; Newton Bishop JA; Taylor C; Debniak T; Lubinski J; Kleina R; Heisele O
    Melanoma Res; 2007 Jun; 17(3):185-91. PubMed ID: 17505264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia.
    Li C; Zhao X; He Y; Li Z; Qian J; Zhang L; Ye Q; Qiu F; Lian P; Qian M; Zhang H
    Pharmacogenet Genomics; 2022 Feb; 32(2):43-50. PubMed ID: 34369425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.